Authors
Loading...
Review explores CD33 isoforms' roles in microglial dysfunction and therapeutic strategies in Alzheimer's disease, suggesting implications for treatment.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: